| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | — |
100% | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 800 | ₹274,400 |
| Retail (Max — 13 Lots) | 13 | 5,200 | ₹1,783,600 |
| S-HNI (Min — 14 Lots) | 14 | 5,600 | ₹1,920,800 |
| B-HNI (Min — 68 Lots) | 68 | 27,200 | ₹9,329,600 |
Q-Line Biotech Ltd is proposing an IPO on NSE SME under the SME category.
Opens 21 May 2026, closes 25 May 2026. Listing: 02 Jun 2026. Apply via ASBA or UPI.
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Borrowings | N/A | N/A | N/A |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Q-Line Biotech Ltd IPO is subscribed 1.00 times by May 25, 2026. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Q-Line Biotech Ltd IPO retail category is subscribed 1.00 times as of 25 May 2026. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 21 May 2026 and closes 25 May 2026. Min investment: ₹137,200 (1 lot = 400 shares). UPI mandate: 5:00 PM on 25 May 2026.
The Q-Line Biotech Ltd IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 31 May 2026. Refunds: on 01 Jun 2026.
The Q-Line Biotech Ltd IPO listing date is 02 Jun 2026, Tuesday. Listed on: NSE SME. Issue price: ₹343. Estimated listing: ₹460. GMP: +₹117.
The Q-Line Biotech Ltd IPO closes on 25 May 2026, Monday. UPI mandate: 5:00 PM on 25 May 2026. Allotment: 31 May 2026. Listing: 02 Jun 2026.